此外，巴国油还与布拉斯科公司签署了一份丙烯供应合同，协议期限5年，于2026年5月生效，总价值约 9.4亿美元。该合同约定的丙烯将由Reduc、Recap和Refap三家炼油厂负责供应，其中Recap炼油厂年供 应量最高可达14万吨，Reduc炼油厂为10万吨，Refap炼油厂的供应量则将逐步提升，到合同末期达到每 年6万吨。 协议的第二部分价值56亿美元，约定自2026年起的11年内，向布拉斯科公司位于里约热内卢州卡希亚斯 公爵市的生产基地供应乙烷、丙烷两类天然气凝析液产品，以及氢气。 中化新网讯 12月18日，巴西国有石油巨头巴西国家石油公司与聚合物生产商布拉斯科共同宣布，历经 数年谈判，双方已达成总价值178亿美元的长期原料供应协议。布拉斯科公司希望借此将其在巴西本土 以石脑油为主的生产模式，逐步转型为采用乙烷等更具成本竞争力的天然气凝析液作为原料，同时取代 并扩充将于2025年底到期的现有供应合同。 协议中金额最高的部分达113亿美元，主要内容为向布拉斯科公司分布在圣保罗州、巴伊亚州和南里奥 格兰德州的工厂供应石化级石脑油，其中涵盖了布拉斯科公司位于南里奥格兰德州的旗舰基地特里温福 联合工厂。这份为期 ...

中化新网讯 11月27日，惠誉评级宣布，由于墨西哥聚乙烯(PE)生产商Braskem Idesa未能支付某只债券的 利息，已将该公司部分债务评级下调至"限制性违约"(RD)级别。此次未支付的是2029年到期债券的利 息，该笔利息原定于上周支付。在为期五天的宽限期结束后，该公司仍未能筹集到足够资金履行偿付义 务。 根据惠誉的评级方法，"限制性违约"适用于存在未纠正偿付违约(本次为2029年债券利息未支付)，但尚 未申请破产或停止运营的发行方。惠誉表示："Braskem Idesa未支付其9亿美元优先担保票据11月18日到 期的利息，在该公司与债权人持续谈判期间，未能纠正这一违约行为，因此我们做出了此次(限制性违 约)评级调整。"此次下调至"限制性违约"是惠誉过去两周内对该公司采取的第三次评级行动。 Braskem Idesa是巴西聚合物巨头布拉斯科与墨西哥Grupo Idesa组建的合资企业，其中布拉斯科持有75% 的股份。该公司在墨西哥韦拉克鲁斯州的科阿特扎科瓦科斯运营着一座年产能105万吨的聚乙烯工厂。 ...

Core Viewpoint - Iran and Switzerland are seeking to expand cooperation in non-sanctioned sectors, with a focus on industrial collaboration and investment opportunities in Iran's free trade zones [1] Group 1: Economic Cooperation - The President of the Iran Chamber of Commerce (ICCIMA), Hassan Zadeh, emphasized the potential for collaboration in various industrial fields, particularly those not affected by sanctions [1] - Iran's economic and industrial capabilities can enhance cooperation not only in economic terms but also in cultural, academic, and social domains [1] Group 2: Investment Opportunities - Iran's free trade zones present attractive investment opportunities for Swiss companies [1] - Despite sanctions, Iran has made significant advancements in advanced technology, knowledge-based industries, petrochemicals, polymers, and medical manufacturing [1] Group 3: Resource Potential - Iran's rich mineral resources, including precious metals and decorative stones, can open new avenues for Swiss investment [1] - The emphasis on identifying mutual capabilities aims to promote business interactions between the private sectors of both countries [1]

Core Insights - The report by Nova Institute highlights the significant growth potential of the biobased polymer industry, with a projected compound annual growth rate (CAGR) of 13% from 2024 to 2029 [2] - Biodegradable biobased polymers are expected to grow at a CAGR of 17%, while non-biodegradable biobased polymers will see a more moderate growth rate of 10% [2] - Asia and North America are set to dominate the global biobased polymer supply, collectively accounting for over 80% of the market by 2029, while Europe’s market share is projected to decline from 13% to 10% [2] Market Growth Potential - The biobased polymer market is anticipated to perform well in 2024, with strong growth expected in the coming years [2] - The average capacity utilization for biodegradable biobased polymers is currently at 65%, indicating significant room for capacity expansion and market development [2] - Non-biodegradable biobased polymers have a high capacity utilization rate of 90%, reflecting strong market demand [2] Product Differentiation - In 2024, a total of 4.2 million tons of biobased polymers are expected to be produced, with cellulose acetate (CA) and epoxy resins leading the market, accounting for 26% and 32% of total production, respectively [3] - 100% biobased PLA is widely used in packaging and medical applications, representing 8% of the total production [3] - The production capacity growth from 2023 to 2024 is primarily driven by the expansion of PLA and epoxy resin capacities in Asia, along with increased polyurethane production globally [3] Industry Challenges and Responses - Global brands are key drivers in the biobased polymer market, actively shifting strategies towards sustainable and climate-friendly solutions [4] - Europe faces significant challenges due to a lack of cohesive policy frameworks, which hampers the full realization of biobased polymers' advantages [4] - The industry also contends with technical bottlenecks and high production costs, making it difficult to compete with traditional fossil-based polymers [4] Future Outlook - The biobased polymer industry is poised for unprecedented growth opportunities, particularly led by Asia's capacity expansion and technological innovations [5] - With ongoing technological advancements, improved policies, and sustained market demand, biobased polymers are expected to capture a larger market share in the future [5] - Collaboration among regions is essential to overcome industry development bottlenecks and elevate the biobased polymer sector to new heights [5]